Director Kevin Rakin bought 70,000 shares of ELUT at $1.06; post-transaction holdings 196,120 shares (+55.5%)
Director Kevin Rakin purchased 70,000 shares of ELUTIA INC. at $1.06 on 2026-01-30, increasing his holdings by 55.5% from 126,120 to 196,120 shares. The company operates with significant financial headwinds: it posted a net loss of $-3.9M against quarterly revenue of $3.3M and experienced -1.5% annual revenue contraction, with market cap of $661.7K reflecting a micro-cap profile. The stock has declined 69.4% from its 52-week high of $3.33, though it has appreciated 58.6% over the trailing 30 days and 10.9% over 90 days. Rakin's cross-ticker track record shows 1 prior buy with a 30-day return of +57.2%, and his same-ticker history at ELUT shows one prior buy on 2025-12-17 that has returned 57.2% so far, though 90-day outcomes for that trade are not yet measurable. This transaction represents a material increase in concentrated exposure to a financially distressed, thinly-capitalized business.
Director Kevin Rakin bought 50,000 shares of ELUT at $0.52; cluster of 4 other insiders bought within 14 days as stock down 87.8% from 52-week high.
Director Kevin Rakin purchased 50,000 shares at $0.52 on 2025-12-17, increasing his holdings by 18.4% to 322,419 shares total. This transaction is part of a multi-insider buying cluster with 4 other insiders acquiring shares within the past 14 days, suggesting coordinated board-level or management confidence. The context is stark: the stock trades at $0.59, down 87.8% from its 52-week high of $4.84, while the company reports $-3.9M net income on $3.3M revenue (latest quarter) with an undisclosed annual revenue decline of -1.5%. The micro-cap market cap of $382.7K makes the company highly illiquid and distressed. Concurrent buying by multiple insiders during a precipitous drawdown and negative earnings backdrop warrants scrutiny of whether insider purchases reflect contrarian conviction in a turnaround scenario or are instead window-dressing in a terminal decline.
